Increase of skin reactivity to histamine after chemotherapy in patients with lung cancer

E. Passowicz-Muszynska, T. Zak-Nejmark, R. Jankowska, M. Ferens-Sieczkowska (Wroclaw, Poland)

Source: Annual Congress 2007 - Therapy of lung cancer
Session: Therapy of lung cancer
Session type: Oral Presentation
Number: 1552

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Passowicz-Muszynska, T. Zak-Nejmark, R. Jankowska, M. Ferens-Sieczkowska (Wroclaw, Poland). Increase of skin reactivity to histamine after chemotherapy in patients with lung cancer. Eur Respir J 2007; 30: Suppl. 51, 1552

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Decrease of skin reactivity to histamine in lung cancer patients
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Chemotherapy for small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


Radiotherapy of nonsmall and small cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=190
Year: 2001

Optimal integration of chemo- and radiotherapy in small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


Biphosphonate, ibantronate improves analgesic therapy in non-small lung cancer (NSCLC) patients with bone metastases
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006

Reduction of peak oxygen consumption in patients with non-small cell lung cancer treated with neoadjuvant chemotherapy
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction?
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Re-challenge of immunotherapy in a lung cancer patient
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021


Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

Changes in lung function tests in lung carcinoma patients due to radiotherapy
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001

Aerosol delivery of chemotherapy in an orthotopic model of lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Lung cancer
Source: Respipedia Article
Year: 2018

Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009